A defined structural fragment of a molecule.
Over the past decade, high-throughput screening (HTS) has become a cornerstone technology of pharmaceutical research. Investments into HTS have been, and continue to be, substantial. A current estimate is that biological screening and preclinical pharmacological testing alone account for ~14% of the total research and development (R&D) expenditures of the pharmaceutical industry 1 . Given its high-throughput and data-rich nature, HTS is very much influenced by advances in automation and miniaturization, and is under constant development [2] [3] [4] . To give a few examples, conventional 96-well plates have by now largely been replaced by 384-well microplates 3, 4 , novel fluorescence-based detection systems have been developed 3 and screening robots have been fully adapted to desktop environments 1, 3 . Moreover, it is anticipated that screening one million compounds per target will become a gold standard for the major pharmaceutical companies as early as 2003 (REF. 4) . However, at the same time, target validation and assay development continue to present major bottlenecks for biological screening 4, 5 . In addition, it is also being recognized that increasing the quality of screening libraries and HTS assays, rather than their quantity, is likely to be an important determinant for the identification of active compounds that have a chance to make it through the drug discovery pipeline 1, 3 . In some ways, this reflects a current trend to 're-rationalize' drug discovery research 5 -that is, departing from a mere 'numbers game' and carrying out fewer, but 'smarter' , experiments. Such efforts are also relevant for resource control in the pharmaceutical industry, taking into account, for example, that the cost of a single HTS programme, without assay development, is still approximately US $75,000 (REF. 1). A knowledge-based approach to drug discovery is further supported by the fact that the number of new drugs introduced per year has remained constant at best over the past years 3, 6 , despite steadily increasing R&D budgets and enormous investments that have been made during the past decade in high-throughput technologies, including HTS and combinatorial chemistry 6 . Various computational approaches are available at present to complement the array of high-throughput discovery technologies, and among these, virtual screening (VS) is one of the most popular. In essence, VS methods are designed for searching large compound databases in silico and selecting a limited number of candidate molecules for testing to identify novel chemical entities that have the desired biological activity 7 . From this point of view, HTS and VS should be highly complementary disciplines 8 . In practice, however, most HTS and VS efforts are much less integrated
INTEGRATION OF VIRTUAL AND HIGH-THROUGHPUT SCREENING
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High-throughput and virtual screening are important components of modern drug discovery research. Typically, these screening technologies are considered distinct approaches, as one is experimental and the other is theoretical in nature. However, given their similar tasks and goals, these approaches are much more complementary to each other than often thought. Various statistical, informatics and filtering methods have recently been introduced to foster the integration of experimental and in silico screening and maximize their output in drug discovery. Although many of these ideas and efforts have not yet proceeded much beyond the conceptual level, there are several success stories and good indications that early-stage drug discovery will benefit greatly from a more unified and knowledge-based approach to biological screening, despite the many technical advances towards even higher throughput that are made in the screening arena.
A defined structural fragment of a molecule.
PHARMACOPHORE
The spatial arrangement of chemical groups or features in a molecule that are known or thought to determine its activity. The most popular pharmacophore models consist of three or four points separated by defined distance ranges. In most cases, pharmacophore geometry is not known from experiment, but is predicted.
MOLECULAR GRAPH
A two-dimensional representation of the connectivity pattern in a molecule, with atoms shown as vertices and bonds as edges. QUANTITATIVE . FIGURE 1 provides an illustration of this principle. A characteristic feature of current VS approaches is their conceptual and algorithmic diversity. FIGURE 2 summarizes the main categories of VS methods.
Structure-or descriptor-based queries. The most straightforward similarity-search calculations are based on 2D SUBSTRUCTURES (or molecular fragments) as templates 15, 16 . Going a step beyond 2D substructure analysis, compound databases can also be searched using 3D molecular queries [17] [18] [19] , particularly PHARMACOPHORE models 17, 18 . These methods generally require the efficient generation of reasonable, low-energy (single or multiple) conformations of database compounds 20, 21 . As with any 3D search method, the crucial assumption is made that database conformations are at least similar to biologically active structures of candidate molecules, which is merely a hypothesis in most cases. In addition to structure-based queries, specialized molecular descriptors can also be used for database searching. Such complex descriptors are designed to, for example, detect similarities in molecular shape and shape-related properties 22, 23 or topological and electronic features 24, 25 between query and test compounds. In addition to single 2D or 3D queries, information from different substructural descriptors can also be combined and reduced to generate descriptor spaces of low complexity for similarity analysis and searching 26 . Recently, MOLECULAR GRAPH representations have also been adapted for VS 27 . Furthermore, when series of analogues that have differential activity are available as training sets, 3D or 4D QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP (QSAR) 28, 29 models can be developed and used for analysing molecular similarity 30 and VS
31
.
Fingerprints. Molecular fingerprints are BINARY BIT STRING representations that capture diverse aspects of molecular structure and properties, and are among the most popular tools for VS. Similar to structure-based queries, fingerprints are the method of choice for cases in which only single hits or leads are available as templates for searching. This analysis proceeds in 'fingerprint space' , which means that a fingerprint is calculated for the template molecule and searched against the corresponding fingerprints of database compounds. Fingerprint overlap is compared and quantified using a similarity measure, such as the TANIMOTO COEFFICIENT (T c ) 13 , and any fingerprint search requires the definition of similarity threshold values. Although all fingerprints are binary bit strings, their design concepts and lengths vary substantially. Simple 2D fingerprints might consist of only ~100 bit positions, each of which detects the presence or absence of a specific structural fragment or codes for a value of a property descriptor 32, 33 (for structural fragment-type descriptors, see also Molecular Design Limited (MDL) online). More complex 2D fingerprints map properties, such as possible connectivity pathways, through molecules to overlapping bit segments and consist of several thousand bits (see Daylight Chemical Information Systems online). By contrast, 3D pharmacophore fingerprints monitor all possible arrangements than might be expected. One of the reasons for this, among others, might simply be that the mindsets of 'experimentalists' on one side and 'theoreticians' on the other are still more distinct from each other than the basic ideas and goals of the HTS and VS disciplines themselves. Given the current technological standards in VS and HTS, there are certainly not many practical limitations that would prevent their integration. Over the past few years, diverse computational concepts and methods have been introduced to analyse screening data, extract knowledge from HTS experiments and derive predictive models of activity, thereby attempting to exploit the complementary nature of HTS and VS. These methods at the interface between HTS and VS, which are designed ultimately to transform random screening into more focused and integrated efforts, are the subject of this Review.
Diversity of VS concepts
VS is often discussed in the context of chemoinformatics 9, 10 . Its main origins are protein-structure-based compound screening or docking 11, 12 and chemical-similarity searching based on small molecules 13 . A detailed discussion of the multitude of available docking algorithms 12 is beyond the scope of this Review. Although structures of target proteins are becoming increasingly available as VS templates, small-molecule-based screening continues to dominate the field, owing to the fact that hit or lead information is still the predominant source of knowledge in many cases. Most VS approaches depend on the application of descriptors of molecular structure and properties 7, 14 that are often classified as one-, two-or three-dimensional (1D, 2D or 3D), depending on the molecular representation from which they are representations [38] [39] [40] , and that highly complex designs are not necessarily superior to more simple ones 33 . FIGURE 3 shows examples of remote-similarity relationships that were successfully recognized with fingerprints of greatly varying complexity.
of predefined, three-or four-point phamacophores 34 in a molecule, as explored by systematic conformational searching, and consist of millions of bits [35] [36] [37] . It is important to note that 2D descriptors or fingerprints often perform as well, or even better, than 3D Figure 2 | Different methods and tools for virtual screening. a | A known protein kinase inhibitor is shown as a template molecule. For single templates, similarity searching is a preferred approach, and popular tools include various two-dimensional (2D) and three-dimensional (3D) structural queries, pharmacophore models, 2D and 3D fingerprints, volume-matching techniques and complex molecular descriptors. b | By contrast, other methods generally require multiple molecules as input (such as a series of kinase inhibitors). These approaches include 2D or 3D quantitative structure-activity relationship (QSAR) models and diverse clustering and partitioning methods.
subdivide chemical space are obtained by BINNING 45, 46 of descriptor axes that define the space. Cell-based partitioning usually relies on the generation of low-dimensional chemical spaces from original descriptor combinations, as shown in FIG. 5. This can be achieved by, for example, the creation of orthogonal descriptor spaces, the removal of descriptor correlations and the generation of novel composite descriptors 44, 47, 48 . However, depending on the specifics of the approach, dimension reduction is not always required for the accurate partitioning of compounds according to biological activity 49 . Furthermore, the efficiency of some dimension-reduction methods can be significantly affected by the increasing size of compound databases. For example, as databases become larger, capturing their intrinsic variability with respect to original descriptor spaces (a prerequisite for lowdimensional representation) becomes more difficult 47 . This also supports the evaluation of alternative partitioning schemes for compound classification 49 . FIGURE 6 summarizes a representative VS experiment. Different VS algorithms usually produce different results and hits, depending on the specifics of the search problem and the method. However, overlapping sets of candidate compounds are frequently obtained when applying different approaches. So, in general, parallel application of different VS methods increases the probability of identifying molecules that have desired activity 50 .
Clustering and partitioning. Compound clustering 38, 41, 42 and partitioning 43 techniques have a long-standing tradition in computer-aided drug discovery. A principal application of these methods is the classification of compound databases into groups of similar compounds. For VS calculations, clustering and partitioning are particularly suitable when series or different sets of active compounds are available as starting points. In such cases, database clusters or partitions into which active molecules fall can be identified, and representative compounds can be selected for biological testing. As discussed later, various clustering and partitioning algorithms have been adopted or developed specifically for the analysis of HTS data sets.
As shown in FIG. 4 , clustering and partitioning methods differ in some respects. Clustering essentially depends on the calculation of intermolecular distances in chemical reference spaces (however defined), whereas partitioning is based on establishing a consistent reference frame that allows the assignment of 'coordinates' to each database molecule independent of others. With the increasing size of data sets under investigation, compound clustering is becoming computationally more challenging, owing to the COMBINATORIAL PROBLEM involved in facilitating pairwise distance comparisons. Cell-based partitioning methods 43, 44 are attractive for VS applications because of their computational efficiency. In this case, 'cells' that BINARY BIT STRING A series of 1 or 0 characters. Each bit position is either set 'on' (that is, set to 1) or 'off' (0), and can account for the presence or absence of a specific feature. TANIMOTO 
COEFFICIENT
The most popular metric for the quantitative comparison of binary molecular fingerprints. This coefficient is defined as
In this formulation, b 1 represents the number of bits that are set on in the first fingerprint, b 2 is the number of bits that are set on in the second fingerprint, and b c is the number of bits common to both fingerprints. If the T c value is 1, then the compared fingerprints are identical.
COMBINATORIAL PROBLEM
As used here, the term describes the situation that the number of possible pairwise comparisons c grows with the number of objects n according to the formula c = n(n -1)/2. So, if n becomes increasingly large, methods that rely on pairwise comparisons of, for example, database molecules become computationally infeasible.
BINNING
This process divides coordinate axes into intervals (typically of equal size). If binning is applied to the axes of 2D and 3D coordinate systems, grids and cells are obtained, respectively. Aqueous solubility and passive absorption. The limited solubility of synthetic compounds under assay conditions continues to be a major obstacle for the reliability and reproducibility of HTS assays 53 . It is therefore unsurprising that methods to predict aqueous solubility of small molecules have become a focal point of chemoinformatics research. Relevant computational approaches can be divided intro three main categories: QUANTITATIVE STRUCTURE-PROPERTY RELATIONSHIP (QSPR) linear-regression-type methods 54 ; neural network simulations 55 ; and molecular-fragment-based,'group contribution' methods 56 . As solubility is easy to measure experimentally, high-quality learning sets are available to derive predictive models. Accordingly, different computational models can achieve better than 90% correlation between prediction and experiment 57 . However, many learning sets that are available consist of organic molecules that are not necessarily 'DRUG-LIKE' . Furthermore, it should be considered that aqueous solubility of test compounds is often more relevant for the reproducibility of assays than the in vivo behaviour of drug candidates. Therefore, estimating passive absorption characteristics (that is, the ability of compounds to pass through membranes without active-transport mechanisms) is also relevant for compound characterization and filtering. For this purpose, QSPR models have been developed 58 . However, in this case, a simple twodescriptor model relating polar molecular surface area (PSA) and LOGP(O/W) of test molecules (FIG. 7) is sufficient to predict absorption characteristics of various data sets with ~70-90% accuracy 59 . As PSA can be approximated well from 2D representations of molecules 60 , these computations are fast and readily available for filtering. As a simple guideline, molecules with a PSA smaller than 140 Å 2 and logP between 0 and 4 usually have favourable absorption characteristics.
Drug-like character. The immense popularity of Lipinski's 'RULE-OF-FIVE' 61 , deduced from a survey of known drugs, is a testament to the fact that it is not well understood what renders a molecule 'drug-like' . So, the field is seeking intuitive and simple guidelines to identify drug candidates. Several similar knowledge-based analyses have been carried out and have revealed some trends. For example, it has been shown that a small number (~30) of core structures are highly recurrent in known drugs 62 . Furthermore, sets of fragments and chemical substitutions that are preferred in drug-like molecules have been identified 63 . Other studies have shown that property-descriptor distributions are different between databases consisting of drug-like and synthetic molecules 64 . Property profiles were also generated for drug-like molecules, and permitted the determination of value ranges of rather simple molecular descriptors, such as molecular mass, atom count or logP, which cover ~80% of these molecules 65 . In addition, a pharmacophore filter has been developed that monitors preferred and undesired functional groups and detects drug-like molecules with about 30% greater frequency than synthetic compounds 66 . Other studies in this area have gone beyond statistical database Having described basic VS concepts, the following sections focus on VS concepts that have increasing complementarity to HTS, including compound-filtering techniques and approaches for the analysis and mining of HTS data sets.
Filter methods
Compound-filtering functions should be regarded as VS methods, although their primary purpose is not the identification of molecules that have desired activity. Rather, filtering is applied to enrich libraries with molecules that have preferred properties or, equally important, to eliminate compounds that have characteristics that are clearly incompatible with the discovery requirements. Compound filtering is most complementary to HTS when it is applied as a 'front-end' technique, before screening. Similar to specific compound-design or selective-acquisition strategies, a primary goal is to improve the quality of screening libraries. As is the case with VS methods in general, the complexity of filter functions varies greatly, ranging from simple rule-based filters to complex NEURAL NETWORK models.
Reactive or toxic groups. An intuitive and simple, but valuable, approach to improving the quality of screening libraries is the removal of compounds that have reactive or otherwise undesired functional groups. For this purpose,'dictionaries' of such groups have been developed to 'filter out' compounds that contain undesired moieties 51, 52 . For example, the rapid elimination of swill (REOS) procedure removes compounds from source libraries that have undesired groups or are too large or flexible 51 . Such 'rule-based' filters are straightforward to implement and modify and are efficient tools to 'prescreen' large compound libraries.
NEURAL NETWORK
Artificial neural networks are collections of mathematical models that are interconnected and organized in different layers. Given this architecture, the models correspond to neurons and the connections to synapses of the nervous system. Neural network simulations are analogous to an adaptive learning process. So, neural nets are typically trained to distinguish between different objects and their properties in learning sets, and the resulting models are then applied to make predictions on test sets. 
DRUG-LIKE
The concept of 'drug-likeness' is based on the premise that drugs share specific molecular characteristics that systematically distinguish them from other synthetic or natural compounds. CNS-negative compounds (which might or might not cross the blood-brain barrier). Nevertheless, both QSAR and neural network models have been reported [70] [71] [72] [73] . From QSAR analysis, the picture emerges that compounds that can cross the blood-brain barrier should have a molecular mass of less than 450 Da and a PSA smaller than 90 73 have trained a neural network to distinguish between CNSactive and -inactive compounds, achieving a level of accuracy similar to general drug predictions; on average ~80%. It is noteworthy that these results were obtained with sets of simple 1D and 2D (structural key) descriptors.
analysis. Gillet et al. 67 have implemented a GENETIC ALGORITHM to assign weight factors to molecular property and shape descriptors to distinguish between drugs and non-drugs, achieving up to sixfold improvement over random predictions. Moreover, neural network simulations have produced predictive models to distinguish between drugs and non-drugs systematically 68, 69 . As is generally the case with neural network approaches, the computed models lack physical interpretability, and are to some extent dependent on the learning sets. Nevertheless,~80% classification accuracy has been achieved in these pioneering investigations.
Blood-brain barrier penetration and CNS activity.
The problem of identifying compounds that can cross the blood-brain barrier and act on the central nervous system (CNS) can be regarded as a special case of drug prediction. Here, the derivation of predictive models is complicated by the fact that reliable learning sets are relatively difficult to obtain -in particular for
The logarithm of the octanol/water partition coefficient (often abbreviated logP) describes the solubility of a compound in octanol (hydrophobic solvent) relative to its solubility in water (polar solvent).
RULE-OF-FIVE
On the basis of statistical analysis of known drugs, candidate compounds are likely to have unfavourable absorption, permeation and bioavailability characteristics if they contain more than 5 hydrogen-bond donors, more than 10 hydrogenbond acceptors, a logP greater than 5 and/or a molecular mass of more than 500 Da.
PRINCIPAL COMPONENT ANALYSIS
(PCA). A mathematical method that captures the variance in a data set with respect to chosen variables, and transforms correlated variables into a smaller number of uncorrelated ones for data presentation.
GENETIC ALGORITHM
Computational implementation of a problem-solving approach that uses principles of biological competition and population dynamics. Model parameters are encoded in a 'chromosome' , and are varied. Chromosomes yield possible solutions to a given problem by means of a fitness function. Chromosomes that correspond to the best intermediate solutions are subjected to operations that are analogous to gene recombination and mutation to produce the next generation. This process continues until solutions reach a predefined convergence criterion. derivation of predictive models of activity for database mining. For a discussion of computational tools and their performance in this area, an important factor that must be taken into account is the quality of the screening data.
HTS data. In general, screening data sets are noisy and error prone, owing, in particular, to the presence of false-positives and false-negatives 4 , which complicates data analysis. For example, cell-based assays have a tendency to produce a relatively high rate of false-positive activity assignments, which is often a consequence of non-specific binding events or toxic effects. Molecules that have promiscuous binding characteristics (as discussed further below) also produce false-positives in various screening assays. On the other hand, degradation of compounds on screening plates, limited compound purity or concentrations that are too low (particularly in mixtures) are major sources of false-negatives. Other factors that lead to systematic errors in HTS data sets include inconsistent plate replication, evaporation of compound solutions under miniaturized assay conditions or solvent effects. To compensate for such effects, visualization techniques and data-mining methods have been developed to remove errors from HTS data sets and improve the quality of raw screening data 79, 80 . Although the approximate nature of HTS-based activity determinations makes it challenging to extract reliable structure-activity relationships from large screening sets, various approaches have been introduced for HTS data analysis and mining, as described below.
Computational approaches.
Owing to their computational efficiency, increasing data volumes do not present a significant problem for most of these methods. Prominent among contemporary approaches has been recursive partitioning (RP), a statistical method for analysing and mining large data sets that consist of active and inactive molecules, which was adapted by Young, Rusinko and colleagues 81, 82 . RP divides data sets along DECISION TREES. At every branch or node, single or multiple 83 BINARY DESCRIPTORS, such as structural fragments, atom-pair or topological descriptors, are selected to divide the data into sets of molecules that share or do not share these descriptors. This leads to enrichment of partitions with active molecules, which can be monitored, for example, by calculating the average biological activity at each node. Finally, structures of active molecules are associated with specific descriptor settings, which in turn can be applied as rules to search databases for compounds that have similar activity. An attractive feature of RP is that it is extremely fast and efficient, and allows the analysis of literally hundreds of thousands of descriptors and very large data sets. In a benchmark study on monoamine oxidase inhibitors, a 15-fold improvement in hit rate over random selection was achieved 82 . Analysis of an HTS data set (for an undisclosed target) revealed an approximate fourfold to fivefold increase in hit rate by application of RP models (that is, less than 20% of the molecules would have to be screened to identify ~75% Other ADME properties. The high attrition rates of clinical candidates 74 present a major problem for the pharmaceutical industry. So, the evaluation and prediction of compound features beyond potency will have an increasingly important role. Ultimately, we would like to better understand the potential of molecules to show efficacy in in vivo settings and 'survive' clinical trials. Although solubility, absorption or blood-brain barrier penetration belong to the spectrum of ADME determinants, many more factors need to be considered when attempting to predict general in vivo characteristics. Among these are, for example, oral availability and metabolic stability, which are beginning to be addressed by computational analysis. QSAR studies have been carried out to build models for the prediction of oral availability based on a set of 232 known drugs, and have yielded 60-70% prediction accuracy, depending on the test set 75 . At present, metabolism studies focus mainly on cytochrome P450 (CYP) isoforms -major drugmetabolizing enzymes in the liver that are determinants of in vivo half-life and clearance rates of drug molecules. Computational approaches to study CYP-related effects vary considerably, and include QSAR-type analyses and modelling of pharmacophores, active sites or enzymatic reactions [76] [77] [78] . Predictive ADME analysis is complicated, as other potentially important parameters, such as drug formulation or drug-drug interactions, are not really considered, at least in current computational investigations. Overall, the computational study of comprehensive metabolic effects is still in its infancy.
Methods for the analysis of HTS data sets
An area of high complementarity between VS and HTS is the analysis of HTS data sets, including extraction of knowledge from HTS experiments and the ADME Absorption, distribution, metabolism and excretion are important effects that determine the in vivo characteristics of drug (candidate) molecules.
DECISION TREE
A data set is successively divided at decision points. At each point, a 'yes' or 'no' decision is made for each object, dividing the data into smaller and smaller subsets along the tree. All objects in a given subset share the same signature of 'yes' or 'no' decisions.
BINARY DESCRIPTORS
These types of descriptor capture two defined states (and not continuous value ranges). Typical examples include a specific substructure or bond pattern. The feature detected by a binary descriptor is either 'present' (state 1) or 'absent' (state 2). Application of binary descriptors allows the classification of molecular data sets by means of decision trees. Recorded are the number of hits for each class that were found within the top 50 compounds when searching with fingerprint 1 (blue) or fingerprint 2 (green). Orange bars show the overlap between corresponding similarity-search calculations (that is, the number of hits per class that were identified by both fingerprints).
(HIV) screening set (see anti-HIV compound screening set on Cancer.gov online), thereby producing overlapping clusters of active compounds and associating diverse chemotypes with anti-HIV activity 88 . This approach extends the application of conventional clustering techniques to test-set selection 89 . Related statistical approaches use specialized 2D substructural descriptors to classify hits into chemically intuitive families of molecules that are associated with biological activity 90, 91 and are in part amenable to the analysis of large screening sets 92 . Although they are effective for visualization and structural interpretation of screening data 91 , these techniques are expected to have lower resolution in identifying structure-activity relationships than decision-tree classification algorithms.
Another statistical method that was specifically designed for knowledge extraction from HTS data is binary QSAR (bQSAR), which was developed by Labute 92 . Based on BAYES' THEOREM, bQSAR establishes relationships between structural features and molecular properties of compounds (through combinations of diverse property descriptors) and their biological activity, and assigns probabilities of activity to molecules. For effective descriptor selection, the bQSAR method has also been coupled to a genetic algorithm 93 . An important aspect of the bQSAR approach is that it does not require accurate activity data, but derives predictive models on the basis of a binary formulation of activity -that is, either 'active' or 'inactive' -relative to predefined activity-threshold values. So, the method is well suited to using 'raw' screening data as input. In pilot studies, greater than 90% accuracy was achieved in the prediction of oestrogen receptor antagonists 94 , although the calculations were affected by boundary effects; that is, the closeness of the activity level of a compound to the chosen threshold value 94 . bQSAR models can be used to screen large databases rapidly for molecules that have a high probability of activity. Moreover, bQSAR analysis is not limited to the prediction of activity, as it can be applied to any molecular property that is amenable to a binary classification scheme. For example, bQSAR has been successfully applied to distinguish between synthetic and naturally occurring molecules systematically 95 , and to classify compound sets relative to threshold values of aqueous solubility 96 . A recently introduced VS approach -a machine-learning technique termed binary kernel discrimination 97 -is conceptually similar to, but distinct from, bQSAR. On the basis of learning sets, it uses binary descriptors to estimate the probability of a molecule to be active. On a monoamine oxidase inhibitor set, the method achieved an approximately twofold enrichment in hits over random selection. On an HTS data set that contained more than 100,000 compounds, a three-to fourfold increase was achieved 97 .
Focused and sequential screening
After discussing the main computational approaches at the interface between VS and HTS, a key question is how the integration of these disciplines is approached. First, VS itself has produced several success stories. Recent examples include a parallel HTS and structure-based VS of the hits) 84 . The RP approach has also been extended through combination with components of other classification or simulation techniques 85, 86 . The frequently observed structural diversity in sets of active compounds presents a potential problem for RP. Active molecules that have different SCAFFOLDS might be separated during the RP process, occur in different terminal nodes and limit descriptor signatures of activity to predominant CHEMOTYPES. The recently introduced 'PHYLOGENETIC-LIKE TREE' algorithm, a clustering method that combines elements of neural nets, genetic algorithms and substructure analysis, addresses these issues by iterative classification of compounds and subclustering 87, 88 . In this case, active compounds can occur in more than one final cluster and can be associated with several descriptors, thereby providing diversified structure-activity correlations. The method accurately classified active compounds in a large and widely used anti-human immunodeficiency virus SCAFFOLD Often defined as the core structure of a small molecule, the scaffold is typically a ring system that has diverse chemical groups attached. Accordingly, it is obtained by removal of these attached groups.
CHEMOTYPE
A family of molecules that has a unique core structure or scaffold. with relatively low throughput, such as cell-based assays 3, 4 . However, for focused screening to be practical, a flexible and efficient compound registration, handling and retrieval infrastructure is essential, as the approach ultimately requires the selection of individual compounds from screening plates 103 . Adding such capabilities to chemistry and HTS laboratories is not necessarily a trivial task. Regardless of technical aspects, focusing has provided a basis for the most popular 'hybrid' screening approach at present, as described below.
Sequential screening. Combining VS-based subset selection and HTS in an iterative manner leads to the process of 'sequential' screening, which represents a truly integrated screening approach. As schematically illustrated in FIG. 9 , different sequential-screening strategies can be pursued, depending on whether hit or lead information is available or not. For example, if active compounds are available as templates, the application of similaritysearch methods aims to identify a library subset enriched with other molecules that have desired activity 8 . If different hits are obtained, the probability significantly increases of finding more active compounds in subsequent steps, as each new hit is available as a separate search template. The availability of multiple search templates often reduces the number of molecules to be screened, as priority can be assigned to candidate compounds on the basis of their frequency of occurrence in different search calculations.
Alternatively, screening libraries can be partitioned or clustered into sets of similar molecules in the presence or absence of hit information. If known active compounds are available as 'baits' , partitions into which active compounds fall are tested. Newly identified hits are again used as baits in subsequent classification steps. If a sequential screening effort is initiated for a target that does not have known active compounds, representative compounds from each partition or cluster are selected initially for testing. Subsequently, those classes that were found to contain novel hits are screened, and the process is repeated as necessary 105 . These iterations might identify series of ANALOGUES early on during the sequentialscreening process and produce initial structure-activity information for chemistry efforts. Following this strategy, a cluster-analysis-based information and datamanagement system for sequential screening has been introduced 106 . Regardless of the specifics of the approach, for sequential screening to be successful, it is crucial that the initial computational analysis leads to a significantly increased hit rate over random selection.
Sequential-screening applications have produced some promising results. In benchmark studies on 18 cancer-cell-line assays, Engels and Venkatarangan 105 showed that two iterations of cluster-based sequential screening produced hit rates of up to 40%. Also, sequential screening based on RP was successfully applied to a panel of 14 G-protein-coupled receptors 107 . Another attractive sequential-screening approach uses 'affinity fingerprints', which are generated by testing selected molecules against sets of reference proteins 108 . So, in contrast to other fingerprint representations, these study that led to the identification of distinct sets of tyrosine phosphatase-1B inhibitors with activities in the low-to mid-micromolar range. In this case, docking calculations outperformed the hit rate of random screening by about three orders of magnitude 98 . Another report described the application of 3D pharmacophore searching in the discovery of VLA-4 integrin antagonists with submicromolar potency 99 . In addition, recent studies have shown that, by combining various 2D and 3D search methods (2D filters and 3D pharmacophores 100 or 2D fingerprints and bQSAR 101 ) and flexible docking, several novel inhibitors of carbonic anhydrase 100 or BCL-xL 101 could be identified by selecting only very few (10-30) candidate compounds for testing.
Focusing. Despite such successes, finding 'needles in haystacks' is not the only possible application of VS technology, and is not the most promising in the context of HTS. For example, VS methods are in general sufficiently accurate to exclude compounds from screening libraries that are not compatible with a given binding site or that are too dissimilar from known active compounds 8 . Going a step further, predictive VS models of the kind described above are also capable of preselecting compound subsets of source libraries that have a higher probability of interacting with a specific target family (such as G-protein-coupled receptors) than with others 102 . Taken together, negative and positive selection by VS allows the identification of relatively small subsets (for example, a few percent) of large screening libraries for target-specific or 'focused' screening efforts 103 . Focusing is well within the 'resolution limits' of current VS approaches and also avoids problems that are associated with selecting too few compounds from VS calculations, as emphasized by the 'SIMILARITY PARADOX' 8 and other studies 104 , and illustrated in FIG. 8 . Focused screening also allows the use of more complex screening assays PHYLOGENETIC TREE This classification structure has its origin in biology to describe evolutionary relationships. It classifies a family of objects into 'most-similar' sets by subdividing them at branch points into successively smaller subsets with increasing object similarity. The final subsets represent unique leaves of the tree. Different from a simple decision tree, a phylogenetic tree structure can create multiple branches at each point.
BAYES' THEOREM
A mathematical formulation that determines the probability that a specific result was due to a particular cause, if multiple possible causes exist. For example, a molecular database consists of 50% synthetic reagents, 30% drug-like molecules and 20% natural products. If the activity rates of synthetic compounds, drug-like molecules and natural products are 1%, 50% and 15%, respectively, what is the probability that a given biological activity in this database is represented by a natural product? in just a few screening iterations, by testing only 250 and 850 molecules, respectively 109 . A retrospective evaluation of several two-stage sequential screening experiments showed that screening 10-20% of library compounds was sufficient to identify 50-80% of available hits 105 , which highlights the attractiveness of the approach.
Structure at last
Finally, to end on a different note, the discussion returns to structure-based VS. A recent study should be mentioned that, for the first time, provided a rationale for the occurrence of 'frequent hitters' 110 . These compounds often non-selectively inhibit various targets in screening experiments. It was found that frequent hitters have a strong tendency to form large aggregates in solution, probably causing apparent enzyme inhibition by an asyet-unknown mechanism 110 . However, as reported by Shoichet and colleagues, frequent hitters have also repeatedly been found by VS, in parallel to HTS. Examples are shown in FIG. 10. Here, VS observations by Shoichet and colleagues have probably triggered the experimental analysis of an important screening phenomenon. However, why frequent hitters are not only detected under assay conditions but also in silico by various structure-based VS calculations remains a mystery at present. This should not distract from some important advances that have recently been made in the fingerprints are experimental in nature. Affinity fingerprint methodology allows the design of different sequential-screening experiments 108, 109 . For example, when targeting 2 different proteins, 8-10 active compounds in a test library (containing 20,000 molecules and 10 active compounds for each target) could be identified interfaces between discovery technologies. In part, this contribution promotes the view that VS and HTS are among the most complementary disciplines in earlyphase drug discovery research, and that their integration is likely to yield more than the sum of the two. It is indeed encouraging to monitor the progress that is made in the development of concepts and methods to foster the integration of VS and HTS efforts. Chemoinformaticsdriven methodologies, such as VS, have a natural tendency to aim at a 'rational' reduction in the number and magnitude of experiments. On occasions, this philosophy might not be consistent with ongoing efforts to increase further the throughput capacity of screening programmes. However, despite inherent approximations and limitations of predictive methods, exemplary studies discussed here indicate that, if applied appropriately, VS analysis can have a substantial impact on the output and success rate of screening experiments. At present, this is perhaps best illustrated by the results of sequential screening, although relevant investigations are still limited to rather few case studies. It is anticipated that the continued development of new technologies for both VS and HTS will further streamline approaches to focused and iterative screening. As genomics and proteomics will probably substantially increase the number of potential therapeutic targets that are available for exploration, an integrated and focused approach to biological screening might become a necessity in the not-too-distant future. From this point of view, building functional interfaces between screening technologies seems to be very timely.
docking arena. Not only were novel carbonic anhydrase and β-lactamase inhibitors identified in independent studies by structure-based VS 100, 111 , but subsequently determined X-ray structures of the respective enzyme-inhibitor complexes also confirmed the predicted binding modes 100, 111 . Furthermore, progress made in the development of knowledge-based scoring functions for docking 112 , and the adoption of mutated enzyme-binding sites with enhanced polar or hydrophobic character for the evaluation of predicted binding modes and scoring schemes 113 , suggests that it might soon be possible to more accurately quantify binding interactions.
Conclusions
As it is becoming evident that high-throughput technologies alone are not likely to improve the productivity of drug discovery research greatly, the integration of diverse discovery technologies is expected to have an increasingly important role. High fall-out rates of clinical candidates present a major problem for the pharmaceutical industry at present and, consequently, there is a clear trend in the field to take 'downstream' compound characteristics beyond potency into account as early as possible during the discovery process. Similar to the situation with combinatorial library design a few years ago, this provides an excellent opportunity for chemoinformatics to interface with experimental discovery programmes. However, although much attention is focused at present on the early assessment of ADME parameters, there are other opportunities to build viable
